Source: International Congress 2014 – Pathogenetic mechanisms in pulmonary fibrosis
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
I. Osinska, D. Wolosz, T. Urbankowski, J. Domagala-Kulawik (Warsaw, Poland). LSC 2014 abstract - M1/ M2 subpopulations of macrophages in patients with sarcoidosis- influence of smoking status. Eur Respir J 2014; 44: Suppl. 58, 1733

Member's Comments

No comment yet.

Related content which might interest you: Impact of smoking habit on lung function in a large cohort sarcoidosis patients. Source: International Congress 2014 – Sarcoidosis Year: 2014 Assessing sarcoidosis activity: Is serum chitotriosidase a reliable marker? Study of 430 patients and 264 healthy controls Source: International Congress 2014 – Pathogenetic mechanisms in pulmonary fibrosis Year: 2014 Does the BTNL2 genotype influence the course of disease in Danish sarcoidosis patients? Source: International Congress 2014 – ILDs: diagnostic and prognostic investigations Year: 2014 Analysis of children’s diffuse parenchymal lung disease from the European Management Platform for Childhood Interstitial Lung Diseases: Frequency of disease categories and treatments used Source: International Congress 2017 – Rare diseases Year: 2017 Mindfulness-based stress reduction in patients with interstitial lung disease: A pilot study Source: International Congress 2014 – ILDs 3 Year: 2014 Treatment of IPF with inhaled IFN-gamma; planning for a clinical trial Source: International Congress 2014 – ILDs 3 Year: 2014 Fibrosis in emphysema: Radiologically occult but histologically prevalent process proportionate to smoking burden Source: International Congress 2014 – ILDs 6 Year: 2014 Mutation alone does not predict the clinical course of surfactant protein C deficiency in children Source: International Congress 2014 – ILDs: pathogenesis and clinical features Year: 2014 LSC 2014 abstract - Evaluation of paraoxonase1 activity and its relationship to the severity of lung impairment in COPD Source: International Congress 2014 – Translational studies in COPD Year: 2014 Change of A549 cells characteristics upon stimulation with BALF of patients with interstitial lung diseases Source: International Congress 2014 – ILDs 4 Year: 2014 Does CRP predicts severity of hospitalized patients with diffuse interstitial lung disease? Source: International Congress 2014 – ILDs 5 Year: 2014 Serum levels of sestrin 2 in patients with sarcoidosis Source: International Congress 2014 – ILDs 6 Year: 2014 Live patient and partner survey on pulmonary fibrosis Source: International Congress 2014 – ILDs: pathogenesis and clinical features Year: 2014 Asbestos-related disorders (ARDs): Influence of pleural plaques and pulmonary fibrosis due to asbestos exposure on lung function decline (LFD) Source: International Congress 2014 – ILDs 5 Year: 2014 Beneficial effect of azithromycin in children with diffuse parenchymal lung disease Source: International Congress 2014 – ILDs: pathogenesis and clinical features Year: 2014 European pulmonary alveolar proteinosis network (EuPAPNet): Results from biomarkers´ investigation Source: International Congress 2014 – Pathogenetic mechanisms in pulmonary fibrosis Year: 2014 Lung asbestos content in patients with lung cancer in different Spanish regions. The AMCANES study Source: International Congress 2016 – Human responses to exposure, including physiological and biomarker outcomes Year: 2016 Residential radon and lung cancer histological types in never smokers Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours Year: 2014 Mucus production, lung inflammation and functional decay in IPF Source: International Congress 2014 – ILDs: pathogenesis and clinical features Year: 2014 Annual changes in pulmonary function are independent prognostic factors for the patients with chronic hypersensitivity pneumonia Source: International Congress 2014 – ILDs 3 Year: 2014